Ted Murphy serves as Executive at Co-Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Ted Murphy has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 23, 2024 involved receiving (via award) 30,000 shares valued at $0.
Ted Murphy currently holds 127,500 shares of Co-Diagnostics, Inc. (CODX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ted Murphy has been a net neutral trader of CODX stock. They have purchased $0 and sold $0 worth of shares.
Ted Murphy's most recent insider trade was on May 23, 2024, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 23, 2023 | CODX | $0 | Award | 18,333 | $N/A | Discretionary |
| Jan 8, 2023 | CODX | $0 | Award | 12,500 | $N/A | Discretionary |
| Nov 23, 2022 | CODX | $0 | Award | 11,667 | $N/A | Discretionary |
| Jan 8, 2022 | CODX | $0 | Award | 12,500 | $N/A | Discretionary |